Abstract The invention described herein allows the production of recombinant retroviruses (retroviral vector particles) from producer cells which are safer and of higher titer than normal. In addition, methods are provided for making helper cells which, when a recombinant retrovirus genome is introduced to make a producer line, produce particles that are targeted toward particular cell types. Methods are also provided for making recombinant retrovirus systems adapted to infect a particular cell type, such as a tumor, by binding the retrovirus or recombinant retrovirus in the particular cell type. Methods are also provided for producing recombinant retroviruses which integrate in a specific small number of places in the host genome, and for producing recombinant retroviruses from transgenic animals.
A retroviral packaging cell line, wherein the packaging cell is generated from a human host cell line, and wherein the retroviral packaging cell line provides gag/pol or gag/pol and env.
Claim 2
Dependent Claim
30 words
A retroviral packaging cell line, wherein the packaging cell is generated from a human host cell line, and wherein the retroviral packaging cell line provides gag/pol or gag/pol and env.
Claim 3
Dependent Claim
14 words
The retroviral packaging cell lines of claim 1 , that provides gag/pol and env.
Claim 4
Dependent Claim
14 words
The retroviral packaging cell lines of claim 2 , wherein the env is VSV-G.
Claim 5
Dependent Claim
22 words
The retroviral packaging cell lines of claim 1 , wherein the retroviral packaging cell line is a non-MLV retroviral packaging cell line.
Claim 6
Dependent Claim
43 words
The retroviral packaging cell lines of claim 4 , wherein the retroviral packaging cell line is a retroviral packaging cell line selected from the group consisting of an RSV packaging cell line, an MMTV packaging cell line, and an HIV packaging cell line.